[{"Assets_0_Q2_USD":308137000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-104932000.0,"NetIncomeLoss_1_Q2_USD":-37191000.0,"NetIncomeLoss_2_Q2_USD":-103012000.0,"StockholdersEquity_0_Q2_USD":275197000.0,"Ticker":"KNSA","CIK":"1730430","name":"KINIKSA PHARMACEUTICALS, LTD.","OfficialName":"Kiniksa Pharmaceuticals Ltd. Class A Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"764985918.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190813"}]